Oncology & Cancer

A novel oncogenic network specific to liver cancer initiation

Researchers headed by Erwin Wagner, the Director of the BBVA Foundation-CNIO Cancer Cell Biology Programme at the Spanish National Cancer Research Centre (CNIO), have deciphered how a stress-inducible gene regulator, AP-1, ...

Medications

Aubagio approved for multiple sclerosis

(HealthDay)—Aubagio (teriflunomide) has been approved by the U.S. Food and Drug Administration to treat adults with relapsing forms of multiple sclerosis (MS).

Genetics

'REST' is crucial for the timing of brain development

Researchers have just shown that the molecule REST acts as an adapter in stem cells, and hope that future studies of REST will contribute to the development of new types of treatments for diseases such as cancer.

page 5 from 6